Indeed, mammalian SYT7 levels are post-transcriptionally modulated by γ-secretase proteolytic activity and APP, linking it to SV trafficking defects in Alzheimer’s disease (Barthet et al., 2018). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.